image
Healthcare - Biotechnology - NASDAQ - US
$ 8.75
-0.906 %
$ 761 M
Market Cap
-2.91
P/E
Price Target Average
225.71%
Revenue Forecast Estimate
133.94%
EBIT Estimate
21.47%
Net Income Estimate
56.55%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Immunome, Inc.
image
Wall Street analysts predict an average 1-year price target for IMNM of $28.5 , with forecasts ranging from a low of $23 to a high of $35 .
IMNM Lowest Price Target Wall Street Target
23 USD 162.86%
IMNM Average Price Target Wall Street Target
28.5 USD 225.71%
IMNM Highest Price Target Wall Street Target
35 USD 300.00%
Price
Max Price Target
Min Price Target
Average Price Target
35353030252520201515101055Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart IMNM

image
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.02020202020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart IMNM

image
$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)2020202020232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart IMNM

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)2020202020232023202420242025202520262026202720272028202820292029